Affiliation:
1. Faculty of Chemistry, Chair of Organic Chemistry, Warsaw University of Technology, Noakowskiego 3, 00-664 Warsaw, Poland
Abstract
Nucleoside analogs (NAs) have been extensively examined as plausible antiviral agents in recent years, in particular since the outbreak of the global pandemic of COVID-19 in 2019. In this review, the structures and antiviral properties of over 450 NAs are collected according to the type of virus, namely SARS-CoV, SARS-CoV-2, MERS-CoV, HCoV-OC43, HCoV-229E, and HCoV-NL63. The activity of the NAs against HCoV-related enzymes is also presented. Selected studies dealing with the mode of action of the NAs are discussed in detail. The repurposing of known NAs appears to be the most extensively investigated scientific approach towards efficacious anti-HCoV agents. The recently reported de novo-designed NAs seem to open up additional approaches to new drug candidates.
Funder
Warsaw University of Technology
Reference129 articles.
1. Forty Years with Coronaviruses;Weiss;J. Exp. Med.,2020
2. Three Emerging Coronaviruses in Two Decades;Guarner;Am. J. Clin. Pathol.,2020
3. WHO Regional Office for the Western Pacific (2006). SARS: How a Global Epidemic Was Stopped, WHO Regional Office for the Western Pacific.
4. The Middle East Respiratory Syndrome (MERS);Azhar;Infect. Dis. Clin. N. Am.,2019
5. (2023, June 05). Middle East Respiratory Syndrome Coronavirus (MERS-CoV). Available online: https://www.who.int/health-topics/middle-east-respiratory-syndrome-coronavirus-mers.